Dengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arboviruses

Journal of Microbiology

Volumn 55, Issue 2, 2017, Pages 81-89

  Suwanmanee, San ^a   Luplertlop, Natthanej ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Aedes mosquito; arboviruses; Dengue virus; flavivirus; microcephaly; Zika virus

Indexed keywords

ADULT; AEDES; ANIMAL; DENGUE; DENGUE VIRUS; HEALTH; HUMAN; MICROCEPHALY; MOSQUITO VECTOR; PATHOGENICITY; PHYSIOLOGY; TRANSMISSION; VIROLOGY; ZIKA VIRUS; ZIKA VIRUS INFECTION;

ADULT; AEDES; ANIMALS; DENGUE; DENGUE VIRUS; GLOBAL HEALTH; HUMANS; MICROCEPHALY; MOSQUITO VECTORS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85010666644     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-017-6494-4     Document Type: Review

References (104)

1. Aguirre, S., Maestre, A.M., Pagni, S., Patel, J.R., Savage, T., Gutman, D., Maringer, K., Bernal-Rubio, D., Shabman, R.S., and Simon, V. 2012. DENV inhibits Type I IFN production in infected cells by cleaving human STING. PLoS Pathog. 8, e1002934.
2. Aliota, M.T., Caine, E.A., Walker, E.C., Larkin, K.E., Camacho, E., and Osorio, J.E. 2016. Characterization of lethal Zika virus infection in AG129 mice. PLoS Negl. Trop. Dis. 10, e0004682.
3. Araujo, L.M., Ferreira, M.L., and Nascimento, O.J. 2016. Guillain-Barré syndrome associated with the Zika virus outbreak in Brazil. Arq. Neuropsiquiatr. 74, 253–255.
4. Aye, K.S., Charngkaew, K., Win, N., Wai, K.Z., Moe, K., Punyadee, N., Thiemmeca, S., Suttitheptumrong, A., Sukpanichnant, S., and Malasit, P. 2014. Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. Human Pathol. 45, 1221–1233.
5. Balasubramanian, S., Anandnathan, K., Shivbalan, S., Datta, M., and Amalraj, E. 2004. Cut-off hematocrit value for hemoconcentration in dengue hemorrhagic fever. J. Trop. Pediatr. 50, 123–124.
6. Balasubramanian, S., Janakiraman, L., Kumar, S.S., Muralinath, S., and Shivbalan, S. 2006. A reappraisal of the criteria to diagnose plasma leakage in dengue hemorrhagic fever. Indian Pediatr. 43, 334–339.
7. Barrows, N.J., Campos, R.K., Powell, S.T., Prasanth, K.R., Schott-Lerner, G., Soto-Acosta, R., Galarza-Munoz, G., McGrath, E.L., Urrabaz-Garza, R., and Gao, J. 2016. A Screen of FDA-approved drugs for inhibitors of Zika virus infection. Cell Host Microbe 20, 259–270.
8. Benelli, G. and Mehlhorn, H. 2016. Declining malaria, rising of dengue and Zika virus: insights for mosquito vector control. Parasitol. Res. 115, 1747–1754.
9. Bhatt, S., Gething, P.W., Brady, O.J., Messina, J.P., Farlow, A.W., Moyes, C.L., Drake, J.M., Brownstein, J.S., Hoen, A.G., and Sankoh, O. 2013. The global distribution and burden of dengue. Nature 496, 504–507.
10. Bollati, M., Alvarez, K., Assenberg, R., Baronti, C., Canard, B., Cook, S., Coutard, B., Decroly, E., de Lamballerie, X., and Gould, E.A. 2010. Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res. 87, 125–148.
11. Buathong, R., Hermann, L., Thaisomboonsuk, B., Rutvisuttinunt, W., Klungthong, C., Chinnawirotpisan, P., Manasatienkij, W., Nisalak, A., Fernandez, S., and Yoon, I.K. 2015. Detection of Zika virus infection in Thailand, 2012-2014. Am. J. Trop. Med. Hyg. 93, 380–383.
12. Buckley, A. and Gould, E.A. 1988. Detection of virus-specific antigen in the nuclei or nucleoli of cells infected with Zika or Langat virus. J. Gen. Virol. 69, 1913–1920.
13. Butler, D. 2016. Brazil asks whether Zika acts alone to cause birth defects. Nature. 535, 475–476.
14. Calvet, G., Aguiar, R.S., Melo, A.S., Sampaio, S.A., de Filippis, I., Fabri, A., Araujo, E.S., de Sequeira, P.C., de Mendonca, M.C., and de Oliveira, L. 2016. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect. Dis. 16, 653–660.
15. Campos, G.S., Bandeira, A.C., and Sardi, S.I. 2015. Zika Virus Outbreak, Bahia, Brazil. Emerg. Infect. Dis. 21, 1885–1886.
16. Cao-Lormeau, V.M., Blake, A., Mons, S., Lastere, S., Roche, C., Vanhomwegen, J., Dub, T., Baudouin, L., Teissier, A., and Larre, P. 2016. Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531–1539.
17. Carod-Artal, F.J. 2016. Epidemiology and neurological complications of infection by the Zika virus: a new emerging neurotropic virus. Rev. Neurol. 62, 317–328.
18. Chao, D.Y., King, C.C., Wang, W.K., Chen, W.J., Wu, H.L., and Chang, G.J. 2005. Strategically examining the full-genome of dengue virus type 3 in clinical isolates reveals its mutation spectra. Virol. J. 2, 72.
19. Chastel, C. 2012. Eventual role of asymptomatic cases of dengue for the introduction and spread of dengue viruses in non-endemic regions. Front. Physiol. 3, 70.
20. Chen, L.H. and Wilson, M.E. 2010. Dengue and chikungunya infections in travelers. Curr. Opin. Infect. Dis. 23, 438–444.
21. Christian, E.A., Kahle, K.M., Mattia, K., Puffer, B.A., Pfaff, J.M., Miller, A., Paes, C., Davidson, E., and Doranz, B.J. 2013. Atomiclevel functional model of dengue virus Envelope protein infectivity. Proc. Natl. Acad. Sci. USA 110, 18662–18667.
22. Constenla, D. and Clark, S. 2016. Financing dengue vaccine introduction in the Americas: challenges and opportunities. Expert. Rev. Vaccines 15, 547–559.
23. Dang, J., Tiwari, S.K., Lichinchi, G., Qin, Y., Patil, V.S., Eroshkin, A.M., and Rana, T.M. 2016. Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3. Cell Stem Cell 19, 258–265.
24. de Alwis, R., Beltramello, M., Messer, W.B., Sukupolvi-Petty, S., Wahala, W.M.P.B., Kraus, A., Olivarez, N.P., Pham, Q., Brian, J., and Tsai, W.Y. 2011. In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl. Trop. Dis. 5, e1188.
25. de Alwis, R., Smith, S.A., Olivarez, N.P., Messer, W.B., Huynh, J.P., Wahala, W.M.P.B., White, L.J., Diamond, M.S., Baric, R.S., and Crowe, J.E. 2012. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc. Natl. Acad. Sci. USA 109, 7439–7444.
26. de Fatima Vasco Aragao, M., van der Linden, V., Brainer-Lima, A.M., Coeli, R.R., Rocha, M.A., Sobral da Silva, P., Durce Costa Gomes de Carvalho, M., van der Linden, A., Cesario de Holanda, A., and Valenca, M.M. 2016. Clinical features and neuroimaging (CT and MRI) findings in presumed Zika virus related congenital infection and microcephaly: retrospective case series study. BMJ 353, i1901.
27. Dejnirattisai, W., Supasa, P., Wongwiwat, W., Rouvinski, A., Barba-Spaeth, G., Duangchinda, T., Sakuntabhai, A., Cao-Lormeau, V.M., Malasit, P., and Rey, F.A. 2016. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat. Immunol. 17, 1102–1109.
28. Dietz, V.J., Nieburg, P., Gubler, D.J., and Gomez, I. 1992. Diagnosis of measles by clinical case definition in dengue-endemic areas: implications for measles surveillance and control. Bull World Health Organ. 70, 745–750.
29. Dowall, S.D., Graham, V.A., Rayner, E., Atkinson, B., Hall, G., Watson, R.J., Bosworth, A., Bonney, L.C., Kitchen, S., and Hewson, R. 2016. A susceptible mouse model for zika virus infection. PLoS Negl. Trop. Dis. 10, e0004658.
30. Duffy, M.R., Chen, T.H., Hancock, W.T., Powers, A.M., Kool, J.L., Lanciotti, R.S., Pretrick, M., Marfel, M., Holzbauer, S., and Dubray, C. 2009. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 360, 2536–2543.
31. Dupont-Rouzeyrol, M., O’Connor, O., Calvez, E., Daures, M., John, M., Grangeon, J.P., and Gourinat, A.C. 2015. Co-infection with Zika and dengue viruses in 2 patients, New Caledonia, 2014. Emerg. Infect. Dis. 21, 381–382.
32. Ellison, D.W., Ladner, J.T., Buathong, R., Alera, M.T., Wiley, M.R., Hermann, L., Rutvisuttinunt, W., Klungthong, C., Chinnawirotpisan, P., and Manasatienkij, W. 2016. Complete genome sequences of zika virus strains isolated from the blood of patients in Thailand in 2014 and the Philippines in 2012. Genome Announc. 4, e00359–16.
33. Faye, O., Freire, C.C., Iamarino, A., Faye, O., de Oliveira, J.V., Diallo, M., Zanotto, P.M., and Sall, A.A. 2014. Molecular evolution of Zika virus during its emergence in the 20(th) century. PLoS Negl. Trop. Dis. 8, e2636.
34. Flingai, S., Plummer, E.M., Patel, A., Shresta, S., Mendoza, J.M., Broderick, K.E., Sardesai, N.Y., Muthumani, K., and Weiner, D.B. 2015. Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy. Sci. Rep. 5, 12616.
35. Gan, V.C. 2014. Dengue: moving from current standard of care to state-of-the-art treatment. Curr. Treat Options Infect. Dis. 6, 208–226.
36. Gebhard, L.G., Filomatori, C.V., and Gamarnik, A.V. 2011. Functional RNA elements in the dengue virus genome. Viruses 3, 1739–1756.
37. Gomes, L., Fernando, S., Fernando, R.H., Wickramasinghe, N., Shyamali, N.L., Ogg, G.S., and Malavige, G.N. 2014. Sphingosine 1-phosphate in acute dengue infection. PLoS One 9, e113394.
38. Guabiraba, R. and Ryffel, B. 2014. Dengue virus infection: current concepts in immune mechanisms and lessons from murine models. Immunology 141, 143–156.
39. Guy, B., Briand, O., Lang, J., Saville, M., and Jackson, N. 2015. Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward. Vaccine 33, 7100–7111.
40. Hadinegoro, R.S. 2012. The revised WHO dengue case classification: does the system need to be modified? Paediatr. Int. Child Health 32, 33–38.
41. Halstead, S.B., Mahalingam, S., Marovich, M.A., Ubol, S., and Mosser, D.M. 2010. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis. 10, 712–722.
42. Hayes, E.B. 2009. Zika virus outside Africa. Emerg. Infect. Dis. 15, 1347–1350.
43. Howard, C.R. 2016. Aedes mosquitoes and Zika virus infection: an A to Z of emergence? Emerg. Microbes Infect. 5, e16.
44. Jouannic, J.M., Friszer, S., Leparc-Goffart, I., Garel, C., and Eyrolle-Guignot, D. 2016. Zika virus infection in French Polynesia. Lancet 387, 1051–1052.
45. Kalayanarooj, S. 2011. Clinical manifestations and management of Dengue/DHF/DSS. Trop. Med. Health 39, 83–87.
46. Kostyuchenko, V.A., Lim, E.X., Zhang, S., Fibriansah, G., Ng, T.S., Ooi, J.S., Shi, J., and Lok, S.M. 2016. Structure of the thermally stable Zika virus. Nature 533, 425–428.
47. Kuhn, R.J., Zhang, W., Rossmann, M.G., Pletnev, S.V., Corver, J., Lenches, E., Jones, C.T., Mukhopadhyay, S., Chipman, P.R., and Strauss, E.G. 2002. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717–725.
48. Lazear, H.M. and Diamond, M.S. 2016. Zika virus: new clinical syndromes and its emergence in the western hemisphere. J. Virol. 90, 4864–4875.
49. Mansuy, J.M., Pasquier, C., Daudin, M., Chapuy-Regaud, S., Moinard, N., Chevreau, C., Izopet, J., Mengelle, C., and Bujan, L. 2016. Zika virus in semen of a patient returning from a non-epidemic area. Lancet Infect. Dis. 16, 894–895.
50. Marchette, N.J., Garcia, R., and Rudnick, A. 1969. Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am. J. Trop. Med. Hyg. 18, 411–415.
51. Martines, R.B., Bhatnagar, J., de Oliveira Ramos, A.M., Davi, H.P., Iglezias, S.D., Kanamura, C.T., Keating, M.K., Hale, G., Silva-Flannery, L., and Muehlenbachs, A. 2016. Pathology of congenital Zika syndrome in Brazil: a case series. Lancet 388, 898–904.
52. Massey, T.H. and Robertson, N.P. 2016. Zika virus and neurology: proving cause and effect. J. Neurol. 263, 1255–1257.
53. Messina, J.P., Brady, O.J., Scott, T.W., Zou, C., Pigott, D.M., Duda, K.A., Bhatt, S., Katzelnick, L., Howes, R.E., and Battle, K.E. 2014. Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol. 22, 138–146.
54. Millichap, J.G. 2016. Zika virus infection and microcephaly. Pediatr. Neurol. Briefs 30, 8.
55. Mlakar, J., Korva, M., Tul, N., Popovic, M., Poljsak-Prijatelj, M., Mraz, J., Kolenc, M., Resman Rus, K., Vesnaver Vipotnik, T., and Fabjan Vodusek, V. 2016. Zika virus associated with microcephaly. N Engl. J. Med. 374, 951–958.
56. Modhiran, N., Watterson, D., Muller, D.A., Panetta, A.K., Sester, D.P., Liu, L., Hume, D.A., Stacey, K.J., and Young, P.R. 2015. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci. Transl. Med. 7, 304ra142.
57. Mondotte, J.A., Lozach, P.Y., Amara, A., and Gamarnik, A.V. 2007. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. J. Virol. 81, 7136–7148.
58. Murray, N.E., Quam, M.B., and Wilder-Smith, A. 2013. Epidemiology of dengue: past, present and future prospects. Clin. Epidemiol. 5, 299–309.
59. Mysorekar, I.U. and Diamond, M.S. 2016. Modeling zika virus infection in pregnancy. N Engl. J. Med. 375, 481–484.
60. Narvaez, F., Gutierrez, G., Perez, M.A., Elizondo, D., Nunez, A., Balmaseda, A., and Harris, E. 2011. Evaluation of the traditional and revised WHO classifications of Dengue disease severity. PLoS Negl. Trop. Dis. 5, e1397.
61. Nasirudeen, A.M., Wong, H.H., Thien, P., Xu, S., Lam, K.P., and Liu, D.X. 2011. RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl. Trop. Dis. 5, e926.
62. Oliveira Melo, A.S., Malinger, G., Ximenes, R., Szejnfeld, P.O., Alves Sampaio, S., and Bispo de Filippis, A.M. 2016. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet. Gynecol. 47, 6–7.
63. Ooi, E.E., Goh, K.T., and Gubler, D.J. 2006. Dengue prevention and 35 years of vector control in Singapore. Emerg. Infect. Dis. 12, 887–893.
64. Organization, W.H. 2011. Comprehensive guildlines for prevention and control of dengue and dengue haemorrhagic fever India: Regional office for South-East Asia World Health House Indraprastha Estate.
65. Paixao, E.S., Barreto, F., Teixeira, M.D., Costa, M.D.N., and Rodrigues, L.C. 2016. History, epidemiology, and clinical manifestations of Zika: A systematic review. Am. J. Public Health 106, 606–612.
66. Panchaud, A., Stojanov, M., Ammerdorffer, A., Vouga, M., and Baud, D. 2016. Emerging role of zika virus in adverse fetal and neonatal outcomes. Clin. Microbiol. Rev. 29, 659–694.
67. Pillet, S. 2009. Infection with Zika virus: recent epidemic in the Islands of Yap (Micronesia). Virologie 13, 183–184.
68. Povoa, T.F., Alves, A.M., Oliveira, C.A., Nuovo, G.J., Chagas, V.L., and Paes, M.V. 2014. The pathology of severe dengue in multiple organs of human fatal cases: histopathology, ultrastructure and virus replication. PLoS One 9, e83386.
69. Puttikhunt, C., Kasinrerk, W., Srisa-ad, S., Duangchinda, T., Silakate, W., Moonsom, S., Sittisombut, N., and Malasit, P. 2003. Production of anti-dengue NS1 monoclonal antibodies by DNA immunization. J. Virol. Methods 109, 55–61.
70. Rajapakse, S., Rodrigo, C., and Rajapakse, A. 2012. Treatment of dengue fever. Infect. Drug Resist. 5, 103–112.
71. Ranjit, S. and Kissoon, N. 2011. Dengue hemorrhagic fever and shock syndromes. Pediatr. Crit. Care Med. 12, 90–100.
72. Rey, F.A. 2003. Dengue virus envelope glycoprotein structure: new insight into its interactions during viral entry. Proc. Natl. Acad. Sci. USA 100, 6899–6901.
73. Rolfe, A.J., Bosco, D.B., Wang, J., Nowakowski, R.S., Fan, J., and Ren, Y. 2016. Bioinformatic analysis reveals the expression of unique transcriptomic signatures in Zika virus infected human neural stem cells. Cell Biosci. 6, 42.
74. Roze, B., Najioullah, F., Ferge, J.L., Apetse, K., Brouste, Y., Cesaire, R., Fagour, C., Fagour, L., Hochedez, P., and Jeannin, S. 2016. Zika virus detection in urine from patients with Guillain-Barré syndrome on Martinique, January 2016. Euro Surveill. 21, doi: 10.2807/1560-7917.ES.2016.21.9.30154.
75. Saiz, J.C., Vazquez-Calvo, A., Blazquez, A.B., Merino-Ramos, T., Escribano-Romero, E., and Martin-Acebes, M.A. 2016. Zika Virus: the Latest Newcomer. Front. Microbiol. 7, 496.
76. Sanofi’s successful Phase 3 trials may lead to first-ever Dengue vaccine in 2015. Hum. Vaccin. Immunother. 10, 3427–3429.
77. Sariol, C.A., Martinez, M.I., Rivera, F., Rodriguez, I.V., Pantoja, P., Abel, K., Arana, T., Giavedoni, L., Hodara, V., and White, L.J. 2011. Decreased dengue replication and an increased anti-viral humoral response with the use of combined toll-like receptor 3 and 7/8 agonists in Macaques. PLoS One 6, e19323.
78. Savidis, G., McDougall, W.M., Meraner, P., Perreira, J.M., Portmann, J.M., Trincucci, G., John, S.P., Aker, A.M., Renzette, N., and Robbins, D.R. 2016. Identification of Zika virus and dengue virus dependency factors using functional genomics. Cell Rep. 16, 232–246.
79. Schmidt, C.W. 2016. Zika in the United States: How are we preparing? Environ. Health Perspect. 124, A157–165.
80. Schwartz, D.A. 2016. Autopsy and postmortem studies are concordant: pathology of zika virus infection is neurotropic in fetuses and infants with microcephaly following transplacental transmission. Arch. Pathol. Lab. Med. doi: http://dx.doi.org/10.5858/rpa.2016-0343-OA.
81. Scott, L.J. 2016. Tetravalent dengue vaccine: a review in the prevention of dengue disease. Drugs 76, 1301–1312.
82. Sikka, V., Chattu, V.K., Popli, R.K., Galwankar, S.C., Kelkar, D., Sawicki, S.G., Stawicki, S.P., and Papadimos, T.J. 2016. The emergence of zika virus as a global health security threat: A review and a consensus statement of the INDUSEM Joint working Group (JWG). J. Global Infect. Dis. 8, 3–15.
83. Sim, S. and Hibberd, M.L. 2016. Genomic approaches for understanding dengue: insights from the virus, vector, and host. Genome Biol. 17, 38.
84. Singhi, S., Kissoon, N., and Bansall, A. 2007. Dengue and dengue hemorrhagic fever: management issues in an intensive care unit. J. Pediatr. 83, S22–S35.
85. Sirohi, D., Chen, Z., Sun, L., Klose, T., Pierson, T.C., Rossmann, M.G., and Kuhn, R.J. 2016. The 3.8 A resolution cryo-EM structure of Zika virus. Science 352, 467–470.
86. Slavov, S.N., Otaguiri, K.K., Kashima, S., and Covas, D.T. 2016. Overview of Zika virus (ZIKV) infection in regards to the Brazilian epidemic. Braz. J. Med. Biol. Res. 49, e5420.
87. Smith, S.A., Zhou, Y., Olivarez, N.P., Broadwater, A.H., de Silva, A.M., and Crowe, J.E. 2012. Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J. Virol. 86, 2665–2675.
88. Smrati Bajpai, M.Y.N. 2016. Zika virus infection, the recent menace of the aedes mosquito. J. Assoc. Physicians India 64, 42–45.
89. Srichaikul, T. and Nimmannitya, S. 2000. Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract. Res. Clin. Haematol. 13, 261–276.
90. Srikiatkhachorn, A. 2009. Plasma leakage in dengue haemorrhagic fever. Thromb. Haemost. 102, 1042–1049.
91. Srikiatkhachorn, A., Krautrachue, A., Ratanaprakarn, W., Wongtapradit, L., Nithipanya, N., Kalayanarooj, S., Nisalak, A., Thomas, S.J., Gibbons, R.V., and Mammen, M.P.Jr. 2007. Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study. Pediatr. Infect. Dis. J. 26, 283–290; discussion 291-282.
92. Tantawichien, T. 2015. Dengue fever and dengue hemorrhagic fever in adults. Southeast Asian J. Trop. Med. Public Health 46, 79–98.
93. Teixeira, M.G., Costa Mda, C., de Oliveira, W.K., Nunes, M.L., and Rodrigues, L.C. 2016. The epidemic of zika virus-related microcephaly in Brazil: detection, control, etiology, and future scenarios. Am. J. Public Health 106, 601–605.
94. Teoh, E.P., Kukkaro, P., Teo, E.W., Lim, A.P.C., Tan, T.T., Yip, A., Schul, W., Aung, M., Kostyuchenko, V.A., and Leo, Y.S. 2012. The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci. Transl. Med. 4, 139ra83.
95. Thisyakorn, U. and Thisyakorn, C. 2014. Latest developments and future directions in dengue vaccines. Ther. Adv. Vaccines 2, 3–9.
96. Toan, N.T., Rossi, S., Prisco, G., Nante, N., and Viviani, S. 2015. Dengue epidemiology in selected endemic countries: factors influencing expansion factors as estimates of underreporting. Trop. Med. Int. Health 20, 840–863.
97. van der Linden, V., Filho, E.L., Lins, O.G., van der Linden, A., Aragao Mde, F., Brainer-Lima, A.M., Cruz, D.D., Rocha, M.A., Sobral da Silva, P.F., and Carvalho, M.D. 2016. Congenital Zika syndrome with arthrogryposis: retrospective case series study. BMJ 354, i3899.
98. van Hemert, F. and Berkhout, B. 2016. Nucleotide composition of the Zika virus RNA genome and its codon usage. Virol. J. 13, 95.
99. Waddell, L.A. and Greig, J.D. 2016. Scoping review of the zika virus literature. PLoS One 11, e0156376.
100. Whitehorn, J. and Simmons, C.P. 2011. The pathogenesis of dengue. Vaccine 29, 7221–7228.
101. Wikan, N., Suputtamongkol, Y., Yoksan, S., Smith, D.R., and Auewarakul, P. 2016. Immunological evidence of Zika virus transmission in Thailand. Asian Pac. J. Trop. Med. 9, 141–144.
102. Yacoub, S., Wertheim, H., Simmons, C.P., Screaton, G., and Wills, B. 2014. Cardiovascular manifestations of the emerging dengue pandemic. Nat. Rev. Cardiol. 11, 335–345.
103. Yockey, L.J., Varela, L., Rakib, T., Khoury-Hanold, W., Fink, S.L., Stutz, B., Szigeti-Buck, K., Van den Pol, A., Lindenbach, B.D., and Horvath, T.L. 2016. Vaginal exposure to zika virus during pregnancy leads to fetal brain infection. Cell 166, 1247–1256.
104. Zanluca, C., Mazzarotto, G.A., Bordignon, J., and Duarte Dos Santos, C.N. 2014. Development, characterization and application of monoclonal antibodies against Brazilian Dengue virus isolates. PLoS One 9, e110620.